Company / SG&A per Share
Adaptive Biotechnologies Corp SG&A per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.49
FY2025
5-year range
$0.49 / $0.63
FY2021-FY2025
Trend
-2.0%
vs FY2024
Sector context
#167 of 210
Health Care
What the data says
Adaptive Biotechnologies Corp's sg&a per share of $0.49 is lower than 80% of companies in the Health Care sector (FY2025). SG&A per Share has declined for 3 consecutive years, from $0.63 in FY2022 to $0.49 in FY2025.
Based on SEC 10-K filings.
0.49 in FY2025 with a 5-year CAGR of +4.5%.
Improved from $0.59 to $0.49 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -7.7%
- 5-Year CAGR
- +4.5%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 210This company $0.49 Sector average $29.50
▼
-98.3% below sector average
Key checks
Key Insights
- Adaptive Biotechnologies Corp's sg&a per share has declined for 3 consecutive years.
- In FY2025, sg&a per share decreased 2.0% year-over-year.
- Ranks #167 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.49 | -2.0% |
| FY2024 | $0.50 | -14.4% |
| FY2023 | $0.59 | -6.3% |
| FY2022 | $0.63 | +15.7% |
| FY2021 | $0.54 | +36.8% |
| FY2020 | $0.40 | -83.3% |
| FY2019 | $2.36 | +46.2% |
| FY2018 | $1.62 | +23.6% |
| FY2017 | $1.31 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026